Skip to content

Story: Gilead Sciences May Have Found A Cure For HIV

  • Dorrit Walsh

May 2015 Examples of media coverage: Gilead Sciences (GILD) May Have Found A Cure For HIV! – CNA Finance, May 18, 2015 This Experimental Drug Could Finally Cure HIV – Motley Fool, May 18, 2015‎ Original source: Unknown, possibly a…

Read more

Story: Doctors “Cure” HIV Patient with Cord Blood Transplant

  • Dorrit Walsh

November 2014 Examples of media coverage: Primer Paciente “Curado” del VIH por un Trasplante de Sangre de Cordón Umbilical – El Mundo, November 6, 2014 Doctors “Cure” HIV Patient with Blood Transplant – Local: Spain’s News in English, November 6,…

Read more

Story: French Scientists Find Mechanism for Spontaneous HIV Cure

  • Dorrit Walsh

November 2014 Examples of media coverage: French Scientists Find Mechanism for Spontaneous HIV Cure
 – Agence France-Presse, November 4, 2014 Scientists See Mechanism for Spontaneous HIV “Cure” (Update) –
 Agence France-Presse, November 4, 2014 HIV: Genetic Mutation Leads to Two Men…

Read more

Tuberculosis Research at Risk as Big Pharma Shutters Programs

  • Chad Cipiti
Worldwide governments, foundations, and companies invested US$676.7 million in research to develop new drugs, vaccines, and diagnostics against tuberculosis (TB) in 2013—barely one-third of the US$2 billion that experts estimate the world must spend each year to end the global TB epidemic—according to an analysis released today by Treatment Action Group.
Read more

Story: Gene Editing Technique Removes HIV from Infected Cells

  • Dorrit Walsh

July 2014 Examples of media coverage: Researchers Find New Way to Kick Out HIV from Infected Cells– Time, July 21, 2014 Temple Researchers Snip Out Dormant HIV from Cells– Philadelphia Enquirer, July 22, 2014 Genome Editing Cuts Out HIV– Scientist, July 21,…

Read more

Letter Urging AstraZeneca to Continue to Invest in TB Research

  • Dorrit Walsh

February 13, 2014 TAG, CRAG, and the TB CAB sent an open letter to AstraZeneca urging their continued investment in tuberculosis research despite the cessation of AstraZeneca’s Neglected Tropical Diseases, Tuberculosis, and Malaria Program. Read/Download the TAG, CRAG, TB CAB…

Read more
Back To Top